Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarlowe Regulatory News (MRL)

  • This share is currently suspended. It was suspended at a price of 440.00
  • There is currently no data for MRL

Total Voting Rights

3 Feb 2025 08:44

RNS Number : 6416V
Marlowe PLC
03 February 2025
 

3 February 2025

 

Marlowe plc

Total Voting Rights

 

In accordance with section 5.6.1 of the Financial Conduct Authority's (FCA) Disclosure Guidance and Transparency Rules (DTRs), Marlowe plc ("Marlowe" or the "Group") hereby notifies the market of the following:

The Group's issued capital as at 31 January 2025 consists of 81,784,240 ordinary shares of 50p each ("Ordinary Shares") with voting rights attached. Of these, no Ordinary Shares are held exclusive of voting rights in Treasury.

Therefore, the total number of voting rights in Marlowe as at 31 January 2025 is 81,784,240.

Shareholders may use the figure of 81,784,240 Ordinary Shares as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in Marlowe under the DTRs.

 

 

For further information:

 

 

 

Marlowe plc

Lord Ashcroft, Interim Non-Executive Chair

Adam Councell, Chief Financial Officer

Benjamin Tucker, Head of Group Reporting

 

www.marloweplc.com

Tel: +44 (0)20 3813 8498

IR@marloweplc.com

 

Cavendish Capital Markets Limited (Nominated Adviser & Broker)

Ben Jeynes

George Lawson

Tel: +44 (0)20 7220 0500

FTI Consulting

Nick Hasell

Alex Le May

Tel: +44 (0)20 3727 1340

 

About Marlowe plc

Marlowe is a leader in business-critical services which ensures compliance with strict regulations and insurance requirements across Fire Safety & Security and Water & Air Hygiene. The Group has a national footprint and serves approximately 27,000 customers across office complexes, high streets & leisure facilities, manufacturing plants and industrial estates, and include thousands of SMEs, local authorities, facilities management providers, multi-site NHS trusts and FTSE 100 companies.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRTJMPTMTIMMJA
Date   Source Headline
6th Jun 20259:22 amRNSForm 8.3 - Marlowe PLC
6th Jun 20259:19 amRNSForm 8.3 - Marlowe PLC
6th Jun 20259:06 amBUSForm 8.3 - Marlowe PLC
6th Jun 20257:00 amRNSForm 8.3 - Mitie Group plc
6th Jun 20257:00 amRNSForm 8.3 - Marlowe plc
5th Jun 20256:19 pmRNSForm 8.3 MARLOWE PLC
5th Jun 20255:25 pmBUSForm 8.3 - Marlowe plc
5th Jun 20253:47 pmRNSForm 8.3 - Marlowe PLC - correction
5th Jun 20253:44 pmBUSForm 8.3 - Marlowe plc
5th Jun 20253:20 pmRNSForm 8.3 - Marlowe plc
5th Jun 20253:14 pmRNSForm 8.3 - MITIE GROUP PLC
5th Jun 20252:57 pmRNSForm 8.3 - Mitie Group plc
5th Jun 20252:10 pmRNSForm 8.3 - Marlowe plc
5th Jun 20251:54 pmRNSForm 8.3 - Marlowe plc
5th Jun 20251:38 pmGNWForm 8.3 - Marlowe plc - Octopus Investments
5th Jun 20251:26 pmRNSForm 8.3 - Marlowe plc
5th Jun 202512:50 pmRNSForm 8.3 - Marlowe plc
5th Jun 202512:21 pmRNSForm 8.3 - Marlowe plc
5th Jun 202512:00 pmRNSForm 8.5 (EPT/RI) - Marlowe Plc
5th Jun 202512:00 pmRNSForm 8.5 (EPT/RI) - Mitie Group Plc
5th Jun 202512:00 pmRNSForm 8.5 (EPT/RI) - Marlowe Plc
5th Jun 202511:58 amRNSForm 8.5 (EPT/RI) - MARLOWE PLC
5th Jun 202510:57 amGNWForm 8.3 - [MARLOWE PLC - 04 06 2025] - (CGWL)
5th Jun 20259:39 amRNSForm 8.5 (EPT/NON-RI)
5th Jun 20257:00 amRNSRecommended cash and share offer for Marlowe PLC
5th Jun 20257:00 amBUSForm 8.3 - Marlowe plc
4th Jun 20253:49 pmRNSForm 8.3 - Mitie Group plc
4th Jun 20253:48 pmRNSForm 8.3 - Marlowe plc
4th Jun 20252:22 pmGNWForm 8.3 - Marlowe Plc
4th Jun 202512:43 pmGNWForm 8.3 - Marlowe plc - Octopus Investments
4th Jun 202511:03 amRNSResponse to Press Speculation
27th May 20259:45 amRNSHolding(s) in Company
23rd May 202510:00 amRNSHolding(s) in Company
16th May 20254:20 pmRNSHolding(s) in Company
16th May 20251:27 pmRNSHolding(s) in Company
15th May 20252:05 pmRNSHolding(s) in Company
13th May 20259:41 amRNSHolding(s) in Company
9th May 202511:16 amRNSHolding(s) in Company
8th May 20251:23 pmRNSHolding(s) in Company
1st May 20257:00 amRNSTotal Voting Rights
29th Apr 202511:36 amRNSExercise of Share Options and Total Voting Rights
28th Apr 20257:05 amRNSAdditional Share Buyback Programme
28th Apr 20257:00 amRNSFY25 Trading Update
25th Apr 20257:00 amRNSTransaction in Own Shares
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20252:36 pmRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.